June 30, 2025
Now available YEZTUGO®
YEZTUGO® (lenacapavir) a human immunodeficiency virus type 1 (HIV-1) capsid inhibitor, is indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35 kg who are at risk for HIV-1 acquisition. Individuals must have a negative HIV-1 test prior to initiating YEZTUGO.